Evidence map›Paper›PMID 30414395›Full record

ReviewThe Journal of allergy and clinical immunology2019

Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council.

Kilian Eyerich, Sara J Brown, Bethany E Perez White, Reiko J Tanaka, Robert Bissonette, Sandipan Dhar, Thomas Bieber, Dirk J Hijnen, Emma Guttman-Yassky, Alan Irvine and 6 more

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Current research landscape and future prospects of in silico modeling approaches for atopic dermatitis.JID innovations : skin science from molecules to population health · 2026
    Review
  3. Article
  4. Skin as a Potential Entry Point for SARS-CoV-2 Virus.International journal of molecular sciences · 2026
    Article
  5. Article
  6. SKIN AS A POTENTIAL ENTRY POINT FOR SARS-COV-2.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Enhancing Transcutaneous Drug Delivery: Advanced Perspectives on Skin Models.JID innovations : skin science from molecules to population health · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Development ofAnnals of dermatology · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 15 institutions in 9 countries.

Kilian EyerichDepartment of Dermatology and Allergy, Technical University of Munich, Munich, Germany; Center of Allergy and Environment (ZAUM), HMGU and Technical University of Munich, Munich, Germany. Electronic address: kilian.eyerich@tum.de.
Sara J BrownSkin Research Group, School of Medicine, University of Dundee, Dundee, United Kingdom; Department of Dermatology, Ninewells Hospital and Medical School, Dundee, United Kingdom.
Bethany E Perez WhiteDepartment of Dermatology and Skin Tissue Engineering Core, Feinberg School of Medicine, Northwestern University, Chicago, Ill.
Reiko J TanakaDepartment of Bioengineering, Imperial College London, London, United Kingdom.
Robert BissonetteInnovaderm Research, Montreal, Quebec, Canada.
Sandipan DharDepartment of Pediatric Dermatology, Institute of Child Health, Kolkata, India.
Thomas BieberDepartment of Dermatology and Allergy, University of Bonn, Bonn, Germany; Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland.
Dirk J HijnenDepartment of Dermatology, Erasmus University Medical Center (Erasmus MC), Rotterdam, the Netherlands.
Emma Guttman-YasskyIcahn School of Medicine at Mount Sinai Medical Center, New York, NY.
Alan IrvineTrinity College Dublin, National Children's Research Centre, Paediatric Dermatology Our Lady's Children's Hospital, Dublin, Ireland.
Jacob P ThyssenDepartment of Dermatology and Allergy, National Allergy Research Centre, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Christian VestergaardDepartment of Dermatology, Aalborg University Hospital, Aalborg, Denmark.
Thomas WerfelMedizinische Hochschule Hannover, Hannover, Germany.
Andreas WollenbergDepartment of Dermatology and Allergy, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Amy S PallerDepartments of Dermatology and Pediatrics and the Skin Disease Research Center, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Nick J ReynoldsDermatological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom. Electronic address: nick.reynolds@ncl.ac.uk.
Aalborg University Hospital · DKErasmus MC · NLGentofte Hospital · DKIcahn School of Medicine at Mount Sinai · USImperial College London · GBInnovaderm (Canada) · CAInstitute of Child Health · INLudwig-Maximilians-Universität München · DEMedizinische Hochschule Hannover · DENorthwestern University · USRoyal Victoria Infirmary · GBTechnical University of Munich · DETrinity College Dublin · IEUniversity of Bonn · DEUniversity of Dundee · GB

Funding

The Role of Keratinocytes as Independent ThermosensorsP30AR057216 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PEREZ WHITE, BETHANY E · 2009 to 2018
$6.0M
Breaking down barriers: defining the role of EphA2 in building epidermal tight junctions in atopic dermatitisK01AR072773 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PEREZ WHITE, BETHANY E · 2018 to 2021
$333k
Department of HealthMedical Research Council MR/N005872/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/P00217X/1NIAMS NIH HHS K01 AR072773NIAMS NIH HHS P30 AR057216Wellcome TrustWellcome Trust 106865/Z/15/Z
6 · The paper itself

Abstract

Atopic dermatitis (AD) is a prevalent disease worldwide and is associated with systemic comorbidities representing a significant burden on patients, their families, and society. Therapeutic options for AD remain limited, in part because of a lack of well-characterized animal models. There has been increasing interest in developing experimental approaches to study the pathogenesis of human AD in vivo, in vitro, and in silico to better define pathophysiologic mechanisms and identify novel therapeutic targets and biomarkers that predict therapeutic response. This review critically appraises a range of models, including genetic mutations relevant to AD, experimental challenge of human skin in vivo, tissue culture models, integration of "omics" data sets, and development of predictive computational models. Although no one individual model recapitulates the complex AD pathophysiology, our review highlights insights gained into key elements of cutaneous biology, molecular pathways, and therapeutic target identification through each approach. Recent developments in computational analysis, including application of machine learning and a systems approach to data integration and predictive modeling, highlight the applicability of these methods to AD subclassification (endotyping), therapy development, and precision medicine. Such predictive modeling will highlight knowledge gaps, further inform refinement of biological models, and support new experimental and systems approaches to AD.

Indexed as

Computer SimulationDermatitis, AtopicModels, ImmunologicalPrecision MedicineSkinBiomarkersHumansBiomarkersAtopic dermatitisatopic eczemaendotypehuman modelsmachine learningmechanistic modelsprecision medicineskin equivalentssystems biologytissue culture models

Identifiers

PMID30414395
PMCPMC6626639
OpenAlexW2900077869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.